CoChat

Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole

Open access

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Abstract

Antibiotic administration disrupts the intestinal microbiota, increasing susceptibility to pathogens such as Clostridium difficile. Metronidazole or oral vancomycin can cure C. difficile infection, and administration of these agents to prevent C. difficile infection in high-risk patients, although not sanctioned by Infectious Disease Society of America guidelines, has been considered. The relative impacts of metronidazole and vancomycin on the intestinal microbiota and colonization resistance are unknown. We investigated the effect of brief treatment with metronidazole and/or oral vancomycin on susceptibility to C. difficile, vancomycin-resistant Enterococcus, carbapenem-resistant Klebsiella pneumoniae, and Escherichia coli infection in mice. Although metronidazole resulted in transient loss of colonization resistance, oral vancomycin markedly disrupted the microbiota, leading to prolonged loss of colonization resistance to C. difficile infection and dense colonization by vancomycin-resistant Enterococcus, K. pneumoniae, and E. coli. Our results demonstrate that vancomycin, and to a lesser extent metronidazole, are associated with marked intestinal microbiota destruction and greater risk of colonization by nosocomial pathogens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jiv256

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. 10.1046/j.1442-9993.2001.01070.x · DOI · Paper page

Cited by

See all 198

Metadata

Authors
Lewis, B. B., Buffie, C. G., Carter, R. A., Leiner, I., Toussaint, N. C., Miller, L. C., Gobourne, A., Ling, L., & Pamer, E. G.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Lewis, Brittany B.
Venue
Journal of Infectious Diseases
Published
2015-04-28
Volume
212
Issue
10
Pages
1656-1665
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2149215043
Cited by
197
References
32
Citations by year
2026: 3 · 2025: 12 · 2024: 13 · 2023: 9 · 2022: 16 · 2021: 23 · 2020: 26 · 2019: 24 · 2018: 27 · 2017: 15 · 2016: 23 · 2015: 5
FWCI
18.05
Type
journal article
Language
en
Open access
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (NIH) (R01 AI42135, AI95706)
  • the Tow Foundation
  • a Medical Scientist Training Program
  • the National Institute of General Medical Sciences
  • NIH (T32GM07739)
  • the Weill Cornell/Rockefeller/Sloan Kettering Tri-institutional MD-PhD Program
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
Clostridium difficile infection, colonization resistance, gut microbiota, oral vancomycin, metronidazole, antibiotic-induced dysbiosis, vancomycin-resistant enterococci, carbapenem-resistant Klebsiella pneumoniae, Escherichia coli, nosocomial pathogens, mouse model
MeSH terms
Animals, Anti-Infective Agents, Bacterial Infections, Disease Models, Animal, Escherichia coli, Female, Klebsiella pneumoniae, Metronidazole, Mice, Inbred C57BL, Vancomycin, Clostridioides difficile, Disease Resistance, Vancomycin-Resistant Enterococci

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole. https://app.cochat.ai/papers/10.1093/infdis/jiv256
The paper
Lewis, B. B., Buffie, C. G., Carter, R. A., Leiner, I., Toussaint, N. C., Miller, L. C., Gobourne, A., Ling, L., & Pamer, E. G. (2015). Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiv256

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.